Anahita Rabiee
Content Writer
Why is it important to think about non-cirrhotic portal hypertension? Let’s start with a case! A 25 yo with history of Common Variable Immunodeficiency (CVID) on monthly IVIG presents to the emergency...
Acute kidney injury (AKI) occurs in approximately 20 % of hospitalized patients with cirrhosis and is associated with increased mortality. The most common causes of AKI in patients with cirrhosis...
In this series, we will talk about the natural history of variceal bleeding, current standard of care, patients defined as high risk for treatment failure, role of early TIPS and its limitations in...
In a follow-up to an outstanding overview of NSBB therapy in liver disease, Part 2 of this series by Anahita Rabiee presents evidence in support of earlier use of NSBBs in cirrhosis. Read on!
In the first post from new LFN author Anahita Rabiee, we are gifted an authoritative review on the Whys and Hows of beta-blockade in decompensated cirrhosis! You definitely want to read this one!
Enter your email here and receive monthly newsletters with new LFN material.
Registration failed. Please try again later.
